Annual EBIT
-$62.80 M
-$595.00 K-0.96%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual earnings before interest & taxes is -$62.80 million, with the most recent change of -$595.00 thousand (-0.96%) on December 31, 2023.
- During the last 3 years, RANI annual EBIT has fallen by -$46.25 million (-279.58%).
- RANI annual EBIT is now -279.58% below its all-time high of -$16.54 million, reached on December 31, 2020.
Performance
RANI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.38 M
+$700.00 K+5.79%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly earnings before interest & taxes is -$11.38 million, with the most recent change of +$700.00 thousand (+5.79%) on September 30, 2024.
- Over the past year, RANI quarterly EBIT has increased by +$700.00 thousand (+5.79%).
- RANI quarterly EBIT is now -320.73% below its all-time high of -$2.71 million, reached on June 30, 2020.
Performance
RANI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$49.71 M
+$5.63 M+10.17%
September 30, 2024
Summary
- As of February 8, 2025, RANI TTM earnings before interest & taxes is -$49.71 million, with the most recent change of +$5.63 million (+10.17%) on September 30, 2024.
- Over the past year, RANI TTM EBIT has increased by +$5.63 million (+10.17%).
- RANI TTM EBIT is now -831.15% below its all-time high of -$5.34 million, reached on March 31, 2020.
Performance
RANI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RANI EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.0% | +5.8% | +10.2% |
| 3 y3 years | -279.6% | +5.8% | +10.2% |
| 5 y5 years | -136.3% | +5.8% | +10.2% |
RANI EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.4% | at low | at high | +34.6% | at high | +30.4% |
| 5 y | 5-year | -279.6% | at low | -320.7% | +60.1% | -831.1% | +30.4% |
| alltime | all time | -279.6% | at low | -320.7% | +60.1% | -831.1% | +30.4% |
Rani Therapeutics Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.38 M(-5.8%) | -$49.71 M(-10.2%) |
| Jun 2024 | - | -$12.09 M(-10.4%) | -$55.34 M(-8.8%) |
| Mar 2024 | - | -$13.48 M(+5.7%) | -$60.66 M(-3.4%) |
| Dec 2023 | -$62.80 M(+1.0%) | -$12.76 M(-25.0%) | -$62.80 M(-5.9%) |
| Sep 2023 | - | -$17.02 M(-2.2%) | -$66.70 M(+1.6%) |
| Jun 2023 | - | -$17.40 M(+11.3%) | -$65.65 M(+2.5%) |
| Mar 2023 | - | -$15.63 M(-6.2%) | -$64.06 M(+3.0%) |
| Dec 2022 | -$62.20 M | -$16.66 M(+4.4%) | -$62.20 M(+5.6%) |
| Sep 2022 | - | -$15.96 M(+1.0%) | -$58.89 M(-17.6%) |
| Jun 2022 | - | -$15.81 M(+14.9%) | -$71.48 M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.77 M(+3.1%) | -$60.98 M(+16.0%) |
| Dec 2021 | -$52.58 M(+217.8%) | -$13.35 M(-53.3%) | -$52.58 M(+17.1%) |
| Sep 2021 | - | -$28.55 M(+437.2%) | -$44.92 M(+134.2%) |
| Jun 2021 | - | -$5.32 M(-1.0%) | -$19.18 M(+15.7%) |
| Mar 2021 | - | -$5.37 M(-5.6%) | -$16.57 M(+0.2%) |
| Dec 2020 | -$16.54 M(-37.8%) | -$5.69 M(+102.1%) | -$16.55 M(+52.4%) |
| Sep 2020 | - | -$2.81 M(+4.0%) | -$10.86 M(+35.0%) |
| Jun 2020 | - | -$2.71 M(-49.3%) | -$8.04 M(+50.7%) |
| Mar 2020 | - | -$5.34 M | -$5.34 M |
| Dec 2019 | -$26.58 M | - | - |
FAQ
- What is Rani Therapeutics Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual EBIT year-on-year change?
- What is Rani Therapeutics Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly EBIT year-on-year change?
- What is Rani Therapeutics Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings TTM EBIT year-on-year change?
What is Rani Therapeutics Holdings annual earnings before interest & taxes?
The current annual EBIT of RANI is -$62.80 M
What is the all time high annual EBIT for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual earnings before interest & taxes is -$16.54 M
What is Rani Therapeutics Holdings annual EBIT year-on-year change?
Over the past year, RANI annual earnings before interest & taxes has changed by -$595.00 K (-0.96%)
What is Rani Therapeutics Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of RANI is -$11.38 M
What is the all time high quarterly EBIT for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly earnings before interest & taxes is -$2.71 M
What is Rani Therapeutics Holdings quarterly EBIT year-on-year change?
Over the past year, RANI quarterly earnings before interest & taxes has changed by +$700.00 K (+5.79%)
What is Rani Therapeutics Holdings TTM earnings before interest & taxes?
The current TTM EBIT of RANI is -$49.71 M
What is the all time high TTM EBIT for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high TTM earnings before interest & taxes is -$5.34 M
What is Rani Therapeutics Holdings TTM EBIT year-on-year change?
Over the past year, RANI TTM earnings before interest & taxes has changed by +$5.63 M (+10.17%)